Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: Glutathione reduction and MRP1 downregulation
Authors:
Open Access
- 28 November 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (2) , 676-684
Abstract
Gallbladder cancer (GBC) is highly malignant with a low response rate after chemotherapy and platinum drugs are currently prominent in the treatment of biliary tract cancers. Therefore, the development of novel strategies to enhance the sensitivity of GBC to platinum drugs is required. In the present study, we examined the effects of verapamil, a classic chemosensitizer whose reported mechanisms of action include inhibiting the transport function of P-glycoprotein (MDR1) or stimulating glutathione (GSH) transport by multidrug resistance-related protein 1 (MRP1), in combination with cisplatin (CDDP), carboplatin (CBP) or oxaliplatin on the GBC cell lines, SGC996 and GBC-SD. Our results demonstrated that the co-treatment with verapamil markedly enhanced the chemosensitivity of GBC cells in comparison with platinum drug treatment alone. The mechanisms involved included GSH reduction and MRP1 downregulation. Verapamil/CDDP co-treatment inhibited tumor xenograft growth via the downregulation of MRP1 expression. MRP1 was highly expressed in human GBC tissue compared to non-tumorous gallbladder tissue. Our data demonstrate that verapamil may be used as a safe chemosensitizer for platinum drugs in the treatment of GBC. It functions by ROS and ATP-binding cassette transporter-related mechanisms.Keywords
This publication has 34 references indexed in Scilit:
- Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract CarcinomaChemotherapy, 2010
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulationBiochemical Pharmacology, 2010
- Current Management of Gallbladder CarcinomaThe Oncologist, 2010
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyBritish Journal of Cancer, 2008
- Gallbladder cancerThe American Journal of Surgery, 2008
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current StrategiesCurrent Molecular Pharmacology, 2008
- Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epitheliumLaboratory Investigation, 2004
- The MRP Family and Anticancer Drug MetabolismCurrent Drug Metabolism, 2001
- Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissuesEuropean Journal of Cancer, 1998